Top Markets
Coin of the day
Jafron Biomedical Co.,Ltd. Jafron Biomedical Co.,Ltd.

Jafron Biomedical Co.,Ltd.

300529
Rang in Aktien #6727
Jafron Biomedical Co.,Ltd. engages in the research and development, production,... Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide. The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.
Aktienkurs
$2.37
Marktkapitalisierung
$1.89B
Veränderung (1 Tag)
-0.24%
Veränderung (1 Jahr)
-29.00%
Land
CN
Handel Jafron Biomedical Co.,Ltd. (300529)

Kategorie

Kursverlauf für Jafron Biomedical Co.,Ltd. (300529)
Höchster Schlusskurs: $2.37 am 2026-08-01

Niedrigster Schlusskurs: $3.58 am 2016-08-01
Kursverlauf der Aktie von Jafron Biomedical Co.,Ltd. von 2016 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -0.53%
2025 -31.60%
2024 30.50%
2023 -29.99%
2022 -44.35%
2021 -24.40%
2020 106.15%
2019 60.77%
2018 26.56%
2017 -32.10%
2016 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$236.22 -3.09%
IE
$16.01 -12.36%
CN
$527.25 9.27%
CH
$170.63 -11.36%
CH
$7.71 11.56%
CN